(NASDAQ: EKSO) Ekso Bionics Holdings's forecast annual revenue growth rate of 29.38% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 11.6%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.68%.
Ekso Bionics Holdings's revenue in 2025 is $17,682,000.On average, 1 Wall Street analysts forecast EKSO's revenue for 2025 to be $513,441,932, with the lowest EKSO revenue forecast at $513,441,932, and the highest EKSO revenue forecast at $513,441,932. On average, 1 Wall Street analysts forecast EKSO's revenue for 2026 to be $663,030,842, with the lowest EKSO revenue forecast at $663,030,842, and the highest EKSO revenue forecast at $663,030,842.
In 2027, EKSO is forecast to generate $848,257,109 in revenue, with the lowest revenue forecast at $848,257,109 and the highest revenue forecast at $848,257,109.